Morepen Laboratories Limited (NSE:MOREPENLAB)

India flag India · Delayed Price · Currency is INR
47.20
+0.56 (1.20%)
Aug 13, 2025, 3:30 PM IST

Elevation Oncology Ratios and Metrics

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 20212017 - 2021
Period Ending
Aug '25 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21 2017 - 2021
25,58426,22021,50013,12717,48814,462
Upgrade
Market Cap Growth
18.75%21.95%63.79%-24.94%20.93%237.00%
Upgrade
Enterprise Value
25,67124,69021,19412,94417,09015,724
Upgrade
Last Close Price
46.6447.8442.0525.8036.5532.10
Upgrade
PE Ratio
27.6322.2222.3633.9417.2014.90
Upgrade
PS Ratio
1.421.431.260.921.121.21
Upgrade
PB Ratio
2.162.212.541.753.033.41
Upgrade
P/TBV Ratio
2.532.602.862.013.694.39
Upgrade
P/FCF Ratio
--1078.33--49.82
Upgrade
P/OCF Ratio
-81.7929.30--28.45
Upgrade
EV/Sales Ratio
1.431.351.250.911.101.31
Upgrade
EV/EBITDA Ratio
15.5212.8313.7215.4111.7312.24
Upgrade
EV/EBIT Ratio
19.2015.1115.5123.0814.4816.02
Upgrade
EV/FCF Ratio
--1063.01--54.17
Upgrade
Debt / Equity Ratio
0.090.090.030.030.230.32
Upgrade
Debt / EBITDA Ratio
0.640.550.190.300.911.06
Upgrade
Debt / FCF Ratio
--14.55--4.71
Upgrade
Asset Turnover
-1.191.421.301.611.58
Upgrade
Inventory Turnover
-4.384.553.864.705.02
Upgrade
Quick Ratio
-0.900.870.900.590.57
Upgrade
Current Ratio
-2.322.212.351.611.31
Upgrade
Return on Equity (ROE)
-11.60%12.08%5.81%20.29%27.43%
Upgrade
Return on Assets (ROA)
-6.65%7.11%3.21%7.65%8.06%
Upgrade
Return on Capital (ROIC)
7.71%9.42%10.33%4.71%11.59%12.55%
Upgrade
Return on Capital Employed (ROCE)
-12.80%15.30%7.10%19.20%21.60%
Upgrade
Earnings Yield
3.62%4.50%4.47%2.95%5.81%6.71%
Upgrade
FCF Yield
--3.51%0.09%-9.66%-6.04%2.01%
Upgrade
Dividend Yield
0.43%0.42%----
Upgrade
Payout Ratio
-----0.50%
Upgrade
Buyback Yield / Dilution
-6.07%-4.95%-1.79%3.39%-15.24%-0.28%
Upgrade
Total Shareholder Return
-5.64%-4.53%-1.79%3.39%-15.24%-0.28%
Upgrade
Updated Feb 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.